Latest aplastic anemia Stories
Randomized Comparator Study to Evaluate Efficacy of Commercially Available Hypomethylating Agents WOODCLIFF LAKE, N.J., Dec.
The Aplastic Anemia & MDS International has announced that the European Committee for Medicinal Products for Human Use has awarded Vidaza a positive opinion for the treatment of myelodysplastic syndromes patients who are not eligible for stem cell transplants.
The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to inform patients that the U.S.
WOODCLIFF LAKE, N.J., July 1, 2008 /PRNewswire/ -- Eisai Corporation of North America today announced the preliminary efficacy data from a trial initiated in 2002 comparing Dacogen(R) (decitabine) to Best Supportive Care (BSC) in elderly patients with myelodysplastic syndromes (MDS).
DUBLIN, Calif., July 1 /PRNewswire-FirstCall/ -- SuperGen Inc.
Alexion Pharmaceuticals has announced that Soliris therapy improved the often disabling fatigue experienced by patients with the rare blood disorder paroxysmal nocturnal hemoglobinuria, independent of improvements in anemia.
CHESHIRE, Conn., June 15 /PRNewswire-FirstCall/ -- Soliris(R) (eculizumab) therapy improved the often disabling fatigue experienced by patients with the rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH) independent of improvements in anemia, according to data presented today at the European Hematology Association (EHA) 13th Congress in Copenhagen (abstract number 0903).
By Coyer, Sharon M Lash, Ayhan Aytekin Anemia is a decrease in erythrocyte mass or amount of hemoglobin from impaired production of erythrocytes, blood loss, or increased erythocyte destruction.
CHICAGO (Reuters) - Stem cells from the bone marrow of patients with severe cases of lupus can help reverse the course of the chronic inflammatory disease when transplanted back into the same patients, according to a study published on Tuesday.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.